Table 2.
Group 1 vs. Group 2 | Group 1 | Group 2 | p | |
---|---|---|---|---|
Mean ±SD | Mean ±SD | |||
No VVM protocol; n = 16 mice |
a Sham vs. Rotation | 2.90 ± 1.39 | 6.90 ± 3.18 | 0.0014 |
b Sham vs. SCO | 2.90 ± 1.39 | 3.27 ± 2.14 | 0.2934 | |
c Rotation vs. SCO + Rotation | 6.90 ± 3.18 | 3.86 ± 1.97 | 0.0026 | |
d Sham vs. SCO + Rotation | 2.90 ± 1.39 | 3.86 ± 1.97 | 0.4627 | |
e Sham vs. Rotation | 3.08 ± 1.67 | 9.08 ± 3.64 | 0.023 | |
VVM protocol; n = 8 mice |
f Rotation vs. VVM + Rotation | 9.08 ± 3.64 | 5.13 ± 1.71 | 0.062 |
g Sham vs. VVM + Rotation | 3.08 ± 1.67 | 5.13 ± 1.71 | 0.117 |
SCO, scopolamine; VVM, Visuo-vestibular mismatch protocol; SD, standard deviation.